UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma ("cSCC ...

UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...

First-in-human results for three investigational inhibitors show anti-tumor activity without unmanageable effects on blood glucose.

Globally, nearly 85% of people with type 2 diabetes are overweight or obese. The link between obesity and diabetes is ...

India faces a diabetes crisis, but there is hope. Many studies show that early intervention and sustained lifestyle changes ...

Approximately 7% of people in the United States (U.S.) have atopic dermatitis – a common, chronic, and flaring inflammatory skin disease, characterized by persistent itch and recurrent skin lesions ...

But as you read through this list, know that the infections that kill quickly aren't common. "They're rare but memorable when ...

Year 2018 is not even a month way and most of us are super excited to unravel the mysteries of the future Right before New Year one question that scampers crazily in our minds is whether the coming ...

TEST ...

2%) associated with Omvoh treatment are upper respiratory tract infections and arthralgia during induction, and upper respiratory tract infections, injection site reactions, arthralgia, rash, headache ...